drugset / Trial / NCT03766750
Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Lima association in the control of type 2 diabetes mellitus
Timeline
- Start
- 2021-12
- Primary completion
- 2023-10
- Completion
- 2023-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Forxiga | Unknown | 10 mg | Oral |
| Subject | LIMA association | Unknown | — | Oral |
| Comparator | Linagliptin | Small molecule | 5 mg | Oral |